Zobrazeno 1 - 10
of 45
pro vyhledávání: '"James Garvin"'
Autor:
Zhezhen Jin, Prakash Satwani, Monica Bhatia, Courtney Baker, Marc D Foca, James Garvin, Holly M. Wobma, Alicia K. Chang, Diane George
Publikováno v:
Pediatric transplantationREFERENCES. 25(4)
BACKGROUND HCT leaves patients in a relative state of immune deficiency both during their initial transplant admission and for several years following discharge. NTM are generally harmless colonizers of the outside environment, but for immunocompromi
Autor:
Prakash Satwani, Courtney Briamonte, Monica Bhatia, Aimee Furey, Diane George, Zhezhen Jin, Justine M. Kahn, Yvette C. Tanhehco, Elana Smilow, Remi Prince, Nita Patel, Sonal Rastogi, James Garvin
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:324-329
To ensure optimal clinical outcomes for patients while retaining adequate protection for donors, the National Marrow Donor Program developed guidelines specifying that up to 20 mL/kg of bone marrow can be harvested from donors. These guidelines, orig
Autor:
Laurie Davis, Monica Bhatia, Larisa Broglie, James Garvin, Prakash Satwani, Susana Moscoso, Matthew Hall, Diane George, Yujing Yao, Zhezhen Jin, Cindy Neunert
Publikováno v:
Transplantation and Cellular Therapy. 27:613.e1-613.e7
Autologous hematopoietic cell transplantation (autoHCT) has become a critical component in the treatment of pediatric malignancies, allowing for high-dose chemotherapy to be given safely and with greater efficacy in a subset of children at high risk
Autor:
Susan Whittier, Marc Foca, Monica Bhatia, Zhezhen Jin, Mary Laird, Rahul Vasudev, Michelle Kolb, Lisa Saiman, Anya Levinson, James Garvin, Andrew L. Kung, Mahvish Qureshi, Alicia K. Chang, Sharon Schwartz, Diane George, Phyllis Della-Latta, Prakash Satwani
Publikováno v:
American Journal of Infection Control. 44:1650-1655
Introduction There are only few reports describing the influence of central line-associated bloodstream infection (CLABSI) prevention strategies on the incidence of bacterial bloodstream infections (BBSIs). Methods We performed a retrospective cohort
Autor:
Andrew L. Kung, Justine M. Kahn, Prakash Satwani, Zhezhen Jin, Michelle Kolb, James Garvin, Katharine Offer, Diane George, Monica Bhatia
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:957-961
Tacrolimus (FK506) is a calcineurin inhibitor and is an essential component of many immunosuppressive regimens. The oral bioavailability of tacrolimus may be affected by many factors, including patient age and gender, as well as by drug-drug interact
Autor:
Diane George, Zhezhen Jin, Prakash Satwani, James Garvin, Matthew Hall, Wallace Bourgeois, Angela Ricci, Monica Bhatia
Publikováno v:
Bone marrow transplantation. 54(5)
The costs associated with allogeneic hematopoietic cell transplantation (alloHCT) are high. Differences in costs and healthcare utilization among potential donor sources for alloHCT are not well characterized in pediatric recipients of alloHCT. One p
Autor:
Jean Sosna, Prakash Satwani, Esra Karamehmet, Diane George, Leah Violago, Andrew L. Kung, Evelyn Rustia, Zhezhen Jin, Chalitha Robinson, Monica Bhatia, Marc Foca, James Garvin
Publikováno v:
Pediatric Transplantation. 19:737-744
HHV-6 is an evolving pathogen in the field of AlloHCT. However, the impact of HHV-6 on AlloHCT outcomes remains to be elucidated. We studied the incidence and clinical impact of HHV-6 viremia in children following AlloHCT. One hundred consecutive chi
Autor:
Chalitha Robinson, Esra Karamehmet, Prakash Satwani, Diane George, Michelle Kolb, Andrew L. Kung, Zhezhen Jin, Katharine Offer, James Garvin, Jean Sosna, Monica Bhatia
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(3):496-502
Only a few studies in children have evaluated the efficacy of prophylactic regimens using tacrolimus on acute graft-versus-host disease (aGVHD). As a result, optimal tacrolimus levels in children after matched sibling donor allogeneic hematopoietic c
Autor:
Mark B. Geyer, R. Hawks, M T Lee, Erin Morris, Joseph Schwartz, Prakash Satwani, M Licursi, Mitchell S. Cairo, Courtney Baker, G. Del Toro, Elana Smilow, Warren A. Zuckerman, D. George, Kavita Radhakrishnan, Monica Bhatia, Zhezhen Jin, James Garvin, L.A. Baxter-Lowe
Publikováno v:
Bone Marrow Transplantation. 49:913-920
BU and CY (BU/CY; 200 mg/kg) before HLA-matched sibling allo-SCT in children with sickle cell disease (SCD) is associated with ~85% EFS but is limited by the acute and late effects of BU/CY myeloablative conditioning. Alternatives include reduced tox
Autor:
Helen Remotti, Andrew T. Turk, Andrew L. Kung, Danielle Pendrick, Hanina Hibshoosh, Stuart J. Andrews, Wendy K. Chung, Filemon S. Dela Cruz, Daniel Diolaiti, Peter L. Nagy, Jennifer A. Oberg, Rebecca J. Zylber, Julia L. Glade Bender, Anthony N. Sireci, Carrie Koval, Jiuhong Pang, Maria Luisa Sulis, Darrell J. Yamashiro, Mahesh M. Mansukhani, Susan J. Hsiao, James Garvin, Stephen G. Emerson
Publikováno v:
Genome Medicine
Background Molecular characterization has the potential to advance the management of pediatric cancer and high-risk hematologic disease. The clinical integration of genome sequencing into standard clinical practice has been limited and the potential